Median Technologies SA (EPA:ALMDT)
France · Delayed Price · Currency is EUR 4.185
+0.125 (3.08%)
Jan 9, 2026, 5:35 PM CET
Median Technologies Market Cap
Median Technologies has a market cap or net worth of €153.64 million as of January 9, 2026. Its market cap has increased by 120.49% in one year.
Market Cap
153.64M
Enterprise Value
188.24M
Revenue
23.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.19
Market Cap Chart
Since May 20, 2011, Median Technologies's market cap has increased from 56.34M to 153.64M, an increase of 172.72%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 153.64M | -11.62% |
| Dec 31, 2025 | 173.83M | 149.47% |
| Dec 31, 2024 | 69.68M | -20.20% |
| Dec 29, 2023 | 87.31M | -37.74% |
| Dec 30, 2022 | 140.24M | -41.91% |
| Dec 31, 2021 | 241.44M | 189.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 127.83B |
| Sanofi | 100.13B |
| Sartorius Stedim Biotech | 21.50B |
| bioMérieux | 13.55B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 9.93B |
| ABIVAX Société Anonyme | 8.05B |
| Virbac | 2.98B |